Based on recent market trends, ETH has nearly doubled since its rebound from the bottom. Currently trading below a key resistance level, the question arises - what's next for ETH
- Red pill/line: ETH breaks through the $2k resistance level, paving the way for a significant bull run.
- Blue pill/line: ETH retests the $1k support level, followed by a continuation of the 2020 market trend.
Aside from Layer 2 (L2) solutions and meme-driven narratives, there is no new major story in the market. The Federal Reserve's interest rate decision remains uncertain, and selling pressure from staked ETH adds to the mix. Considering these factors, I believe the blue scenario has a higher likelihood of playing out.
TO DA MOOOOOOON!!!
NOTE:
Investors should always conduct thorough research and consider their risk tolerance before making any investment decisions. This analysis is for educational and informational purposes only and should not be construed as financial investment advice.
- Red pill/line: ETH breaks through the $2k resistance level, paving the way for a significant bull run.
- Blue pill/line: ETH retests the $1k support level, followed by a continuation of the 2020 market trend.
Aside from Layer 2 (L2) solutions and meme-driven narratives, there is no new major story in the market. The Federal Reserve's interest rate decision remains uncertain, and selling pressure from staked ETH adds to the mix. Considering these factors, I believe the blue scenario has a higher likelihood of playing out.
TO DA MOOOOOOON!!!
NOTE:
Investors should always conduct thorough research and consider their risk tolerance before making any investment decisions. This analysis is for educational and informational purposes only and should not be construed as financial investment advice.
註釋
Blue pill/line on the way~註釋
typo: 2K target done, now we are on 2.8K resistance,
will we down to 1.5K/2K again, or for potential 3.5K first(from ETH/BTC pair)
註釋
Blue pill go go go~免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。